2000
DOI: 10.1017/s1355838200000972
|View full text |Cite
|
Sign up to set email alerts
|

Deletion of a conserved dinucleotide inhibits the second step of group II intron splicing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
23
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(27 citation statements)
references
References 15 publications
4
23
0
Order By: Relevance
“…Certain revertants of the triad mutants, and some revertants with nuclear suppressor mutations regain significant splicing activity in vivo and these are interesting because they do not display second-step defects (Boulanger et al 1995;Schmidt et al 1998). Given the role of J2/3 in formation of gÀg9 and recognition of the 39-splice site, it has been suggested that J2/3 is important only in the second step of splicing (Mikheeva et al 2000), which would imply a major active-site rearrangement between the first and second steps of splicing. The fact that revertants of triad mutants do not have second step defects (Boulanger et al 1995;Schmidt et al 1998) suggests that the catalytic triplex persists through both steps of splicing, which is consistent with site-directed crosslinking studies (DeLencastre et al 2005).…”
Section: Biochemical and Genetic Studies On Function Of The Catalyticmentioning
confidence: 99%
“…Certain revertants of the triad mutants, and some revertants with nuclear suppressor mutations regain significant splicing activity in vivo and these are interesting because they do not display second-step defects (Boulanger et al 1995;Schmidt et al 1998). Given the role of J2/3 in formation of gÀg9 and recognition of the 39-splice site, it has been suggested that J2/3 is important only in the second step of splicing (Mikheeva et al 2000), which would imply a major active-site rearrangement between the first and second steps of splicing. The fact that revertants of triad mutants do not have second step defects (Boulanger et al 1995;Schmidt et al 1998) suggests that the catalytic triplex persists through both steps of splicing, which is consistent with site-directed crosslinking studies (DeLencastre et al 2005).…”
Section: Biochemical and Genetic Studies On Function Of The Catalyticmentioning
confidence: 99%
“…The second major target of cross-linking from photoactivated nucleotides at the 59-splice site is the linker between domains 2 and 3 (J2/3), which contains two highly conserved nucleotides, A587 and G588, which are important for the catalysis of splicing (Jacquier and Michel 1990;Ho Faix 1998;Mikheeva et al 2000). Specifically, crosslinks in set b from s U4 is found to cross-link strongly to A587 and moderately to G588 (Fig.…”
Section: Mapping Of Cross-linksmentioning
confidence: 99%
“…Previous studies have shown that mutations to A587, G588, and A589 significantly impair the second step of splicing (Jacquier and Michel 1990;Mikheeva et al 2000). On the basis of these studies, J2/3 has generally been assumed to play a role only in the second step.…”
Section: Defining J2/3 As An Active-site Componentmentioning
confidence: 99%
See 1 more Smart Citation
“…To test whether the reverse-splicing reaction by linear intron is actually related to the second step of splicing, we created an intron mutant where the consecutive nucleotides G588 and A589, located in the region linking Domains D2 and D3 of ai5g, were deleted (ai5g-DG588,DA589). It was shown previously with a full length forward-splicing construct that this double mutant is almost unable to catalyze the second step of splicing (Mikheeva et al 2000). The concept of microscopic reversibility requires that this mutation will also affect the true reversal of the second splicing step (Ricard 1978).…”
Section: Activity Of the Dg588 Da589 Mutantmentioning
confidence: 97%